Zurich Cantonal Bank’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Hold |
15,487
| – | – | ﹤0.01% | 1758 |
|
|
2025
Q1 | $344K | Hold |
15,487
| – | – | ﹤0.01% | 1819 |
|
|
2024
Q4 | $306K | Buy |
15,487
+7,934
| +105% | +$157K | ﹤0.01% | 1931 |
|
|
2024
Q3 | $189K | Buy |
+7,553
| New | +$189K | ﹤0.01% | 2139 |
|
|
2024
Q2 | – | Sell |
-7,555
| Closed | -$149K | – | 2682 |
|
|
2024
Q1 | $149K | Buy |
7,555
+664
| +10% | +$13.1K | ﹤0.01% | 2212 |
|
|
2023
Q4 | $121K | Sell |
6,891
-120
| -2% | -$2.11K | ﹤0.01% | 2353 |
|
|
2023
Q3 | $122K | Sell |
7,011
-340
| -5% | -$5.91K | ﹤0.01% | 2267 |
|
|
2023
Q2 | $104K | Sell |
7,351
-322
| -4% | -$4.53K | ﹤0.01% | 2338 |
|
|
2023
Q1 | $82.6K | Buy |
7,673
+1,694
| +28% | +$18.2K | ﹤0.01% | 2391 |
|
|
2022
Q4 | $89.6K | Sell |
5,979
-2,570
| -30% | -$38.5K | ﹤0.01% | 2338 |
|
|
2022
Q3 | $110K | Hold |
8,549
| – | – | ﹤0.01% | 2142 |
|
|
2022
Q2 | $83K | Buy |
8,549
+1,385
| +19% | +$13.4K | ﹤0.01% | 2364 |
|
|
2022
Q1 | $71K | Hold |
7,164
| – | – | ﹤0.01% | 2425 |
|
|
2021
Q4 | $84K | Buy |
7,164
+5,327
| +290% | +$62.5K | ﹤0.01% | 2585 |
|
|
2021
Q3 | $21K | Hold |
1,837
| – | – | ﹤0.01% | 2777 |
|
|
2021
Q2 | $26K | Hold |
1,837
| – | – | ﹤0.01% | 2558 |
|
|
2021
Q1 | $34K | Hold |
1,837
| – | – | ﹤0.01% | 2482 |
|
|
2020
Q4 | $32K | Hold |
1,837
| – | – | ﹤0.01% | 2531 |
|
|
2020
Q3 | $28K | Buy |
+1,837
| New | +$28K | ﹤0.01% | 2418 |
|